Skip to search formSkip to main contentSkip to account menu

Cancer/Testis Antigen 2

Known as: LAGE-1, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, CT6.2 
Cancer/testis antigen 2 (210 aa, ~21 kDa) is encoded by the human CTAG2 gene. This protein may play a role in tumorigenesis of several tissues.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Meeting abstracts We report on a 26 patient phase I/II clinical trial ([NCT01352286][1]) to investigate the safety, feasibility… 
2012
2012
Abstract 472 Background: Despite recent therapeutic advances, multiple myeloma (MM) remains primarily an incurable cancer… 
2011
2011
  • X. Yi
  • 2011
  • Corpus ID: 87571904
pcDNA3.1/LAGE-1 eukaryotic expression vector was constructed and transfected into EMT6 cells;BalB/c mice were divided into 4… 
2009
2009
Abstract 4887 Introduction In recent years, the expression of CT antigens has been studied in various malignant neoplasias. Based… 
2006
2006
Introduction: Recently, Jungbluth and collaborators (Blood 2005;106(1):167) demonstrated that CT7 and MAGE-A3/6 are frequently… 
2006
2006
Objectives: To detect new specific gene expressions in squamous cell carcinoma of the esophagus. Methods: Representational… 
2004
2004
OBJECTIVE To investigate the possibility of utilizing cancer-testi (CT) antigens as targets for immunotherapy of non-small cell… 
2003
2003
Cancer-testis (CT) antigens are expressed in a variety of cancers, but not in normal adult tissues, except for germ cells of the… 
Review
2002
Review
2002
Cutaneous lymphomas (CLs) are a heterogeneous group of malignancies of T-cell (cutaneous T-cell lymphoma, CTCL) or B-cell… 
Highly Cited
2001
Highly Cited
2001
Cancer-testis antigens (CTAs) such as MAGE are selectively expressed in various types of human neoplasms but not in normal…